Rivermark Medical, Inc. — Form D/A
Rivermark Medical, Inc. of MILWAUKEE, WI, a company, filed a Form D amendment with the SEC on 2024-10-11. The offering totals $4.1M, of which $4.1M was reported sold. Industry: Other Technology.
Offering
- Filed: 2024-10-11
- Form: D/A
- Accession: 0001893745-24-000003
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $4.1M
- Amount sold: $4.1M
- Investors: 6
- Date of first sale: 2023-07-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-488374
Issuer
- Name: Rivermark Medical, Inc.
- CIK: 0001893745
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 758 N Broadway, Suite 234, MILWAUKEE, WI, 53202
- Phone: 773-307-9665
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Josh Baltzell | Director | Dallas, TX |
| Joseph Biller | Director | Milwaukee, WI |
| Scott Button | Director | Madison, WI |
| Anand Doraiswamy | Director | Dallas, TX |
| Matthew Ercolani | Director | Milwaukee, WI |
| Adam Kadlec | Director | Milwaukee, WI |
| Carter Meyer | Director | South San Francisco, CA |
| Anand Doraiswamy | Executive Officer | Dallas, TX |
| Adam Kadlec | Executive Officer | Milwaukee, WI |
| Christopher Kaster | Director | Milwaukee, WI |
Other filings by this issuer (3)
More